Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
I've been here just under a year, have enjoyed seeing the changes as the company moves from being run by founders to being run by career business builders
Quelles sont les meilleures choses à propos de votre équipe?
humor, responsiveness, openness, integrity, personal interest
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
DEI initiatives that broaden my view & learning
Qu’est-ce qui vous rend le plus heureux au travail?
the people and the ultimate focus on patients
Quelle est la meilleure partie de votre programme de rémunération?
currently get free lunch onsite
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
They are building their relationships with each other and with employees
Other Employee Reviews for Karyopharm Therapeutics
×